Dent Named Associate Director For Clinical Research, Breast Oncology
Medical oncologist Susan F. Dent, MD, FRCPC, was recently named associate director for clinical research for Breast Oncology and co-director of Duke Cardio-Oncology.
“We are extremely excited to welcome Susan Dent, a world-class breast cancer researcher and physician, to Duke Cancer Institute and the Division of Medical Oncology,” said James Abbruzzese, chief, Division of Medical Oncology and associate director of Clinical Research and Training, Duke Cancer Institute. “In addition to her role as associate director for clinical research in the Breast Disease Group, Dr. Dent will continue her work at the interface of cardiology and oncology, an area that she and others have pioneered and that is extremely important to cancer patients as they are living longer lives.”
Previously, Dent was professor of Medicine, University of Ottawa Division of Medical Oncology. There, she also served as research lead for the breast disease site group. She is founder and past president of the Canadian Cardiac Oncology Network (CCON) and was the inaugural co-chair of the first Global Cardio-Oncology Summit (GCOS).
Dent received her medical degree from McMaster University in Ontario, Canada, and completed her postgraduate training in internal medicine at the University of Ottawa. She completed a fellowship in clinical research with the Canadian Cancer Clinical Trials Group.
Dent has served in many capacities, including as a member of the Cancer Ontario Breast Disease Site Practice Guidelines Committee, the IND working group for the Breast Cancer Disease Site Committee of the Canadian Clinical Trials Group, and the Grant Review Panel member for the Canadian Institute of Health Research. She was Vice Chair of the Quality & Clinical Services Committee Department of Medicine, University of Ottawa.
“Susan Dent is a fantastic addition to the Breast Oncology; we are overjoyed to have her join us,” said P. Kelly Marcom, MD, professor of Medicine and director of Breast Oncology at Duke Cancer Institute. “In addition to her extensive breast cancer clinical research experience, she is a world leader in cardio-oncology. Duke is the perfect place for her to further develop this interest. She will be a great colleague and will bring a fresh perspective to our program.”